# Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/non-inferior-clinical-outcomes-of-immune-checkpoint-inhibitors-in-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuri Tasaka,Takayuki Honda,Naoki Nishiyama,Toshiharu Tsutsui,Hiroaki Saito,Haruna Watabe,Kazuhiro Shimaya,Akifumi Mochizuki,Shun Tsuyuki,Tatsuo Kawahara,Rie Sakakibara,Takahiro Mitsumura,Tsukasa Okamoto,Masayoshi Kobayashi,Tomoshige Chiaki,Takaaki Yamashita,Yoshikazu Tsukada,Reiko Taki,Yasuto Jin,Hiroyuki Sakashita,Ichirou Natsume,Kazuhito Saitou,Yoshihiro Miyashita,Yasunari Miyazaki |
| Citations | 40 |
| DOI | 10.1016/j.lungcan.2021.03.014 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3136740877 |
| PMID | 33798901 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Naoki Nishiyama](https://scholariq.org/researchers/naoki-nishiyama/)

## Paper journal

- [Lung Cancer](https://scholariq.org/journals/lung-cancer/)

## Paper primary topic

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Paper topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.